Have We Forgotten About Japan?
Is Japan being ignored as a licensing partner in the biotech industry? Is China now getting all of the attention? Lacerta Bio explores this question.
Is Japan being ignored as a licensing partner in the biotech industry? Is China now getting all of the attention? Lacerta Bio explores this question.
I believe it is fair to say that 2016 was a bit unusual. Thinking about the terminology many of us learned last year leads us to that conclusion: snowflake,…
Today, Derek Lowe points out that Shenzhen Chipscreen received CFDA approval for chid amide (Epidaza), the first drug to be completely discovered, developed and approved exclusively in China.…